T cell activation assay: preclinical research

Newsletter

Target NeuroInflammation:
A practical applications newsletter for inflammations and neurology research.

Register


More Information

Cytokine-stimulated adenocaricoma in vitro assay

An early event thought to participate in the pathogenesis of IBD is the disruption of the gastrointestinal epithelial barrier. This disruption leads to the mixing of microbial pathogens from lmen with antigen presenting cells in the lamina propria producing an inflammatory response. The resulting pro-inflammatory cytokines and chemokines recruit and activate leukocytes, regulate the integrity of the epithelial barrier and stimulate the production of chemokines from epithelial cells. Together these events lead to the inflammation of the intestines.

In vitro cytokine-stimulated human colon adenocaricoma assay    Get Proposal
Cell System human colon adenocarcinoma cells (HT29)
Length 1 week
Stimulant LPS
Reference epigallocatechin-3-gallate (EGCG)
Readouts

PGE2, MIP-3a, IP-10, IL-8

 

preclinical contract research - HT29 in vitro screening assay

Figure: HT29 cells were stimulated with TNF-a for 24 hours in the presence of vehicle control and ECGC. Cell culture supernatants were assays for IP-10, IL-8, MIP-3a and PGE2. Mean values are shown. Error bars represent standard deviations. 


Interesting Fact

Preclinical drug discovery and development outsourcing can lower development costs, decrease risk, speed up timelines and increase the confidence of potential partners.

Client Testimonial

“Among all the CROs that I have used over the years, including recently for inflammation, MD Biosciences has been one of the very best in terms of scientific knowledge, expertise, data quality, timelines, flexibility and personal contacts.”

O.B., Director of Preclinical Research Pharmaceutical Company